Cenegermin for the treatment of dry eye disease.
Drugs Today (Barc)
; 59(3): 113-123, 2023 Mar.
Article
in En
| MEDLINE
| ID: mdl-36847622
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Dry Eye Syndromes
/
Nerve Growth Factor
Limits:
Humans
Language:
En
Journal:
Drugs Today (Barc)
Journal subject:
MEDICINA OCUPACIONAL
/
SAUDE AMBIENTAL
Year:
2023
Document type:
Article
Affiliation country:
Italy
Country of publication:
Spain